T1	intervention 0 26	Hypofractionated radiation
T2	No-of-participants 868 892	One hundred thirty-three
T3	duration 951 961	5.03 years
T4	duration 632 653	between 2003 and 2008
T5	outcome-Measure 773 803	local recurrence-free survival
T6	outcome-Measure 805 827	breast cancer survival
T7	outcome-Measure 829 845	overall survival
T8	outcome-Measure 850 866	acute toxicities
T9	intervention-value 963 968	Three
T10	outcome 984 1000	local recurrence
T11	outcome 1032 1069	5-year local recurrence-free survival
T12	intervention-value 1073 1078	97.6%
T13	outcome 1080 1106	Five-year overall survival
T14	outcome 1111 1140	5-year breast cancer survival
T15	intervention-value 1146 1151	74.7%
T16	intervention-value 1156 1161	77.7%
T17	outcome 1274 1295	grade 2 skin toxicity
T18	intervention-value 1300 1305	10.7%
T19	intervention-value 1311 1313	no
T20	outcome 1335 1356	grade 3 skin toxicity
